You are here

  • Home
  • Archive
  • Volume 106, Issue 10
  • Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

Article metrics

Article menu
Clinical science
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study

 

Online download statistics by month:

Online download statistics by month: May 2021 to August 2024

AbstractFullPdf
May 202112451207770
Jun 2021182718171506
Jul 202110541053752
Aug 202122421463
Sep 202115214335
Oct 202115114652
Nov 202116616266
Dec 202116315939
Jan 202211511129
Feb 202215515222
Mar 202218518539
Apr 202221521142
May 202220620027
Jun 202225525933
Jul 202219519032
Aug 202219519521
Sep 2022877889124
Oct 2022612609127
Nov 202239939870
Dec 202238939452
Jan 202330630053
Feb 202326226348
Mar 202330630454
Apr 202318017246
May 202312011742
Jun 202312311527
Jul 202312112421
Aug 2023697029
Sep 2023514922
Oct 2023636020
Nov 2023727235
Dec 2023656039
Jan 2024584631
Feb 202418616837
Mar 2024194186105
Apr 202419219552
May 202418918655
Jun 202419918950
Jul 2024746934
Aug 2024634741
Total11673114864742